Bluejay Diagnostics (BJDX) Cash from Operations (2020 - 2026)
Bluejay Diagnostics recorded quarterly Cash from Operations of 1589200.0 in Q1 2026, down 9.23% quarter-over-quarter from 1454870.0 in Q4 2025, and down 34.13% year-over-year from 2412480.42 in Q1 2025.
Bluejay Diagnostics' Cash from Operations history runs 7 years deep, the most recent figure standing at 1589200.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 34.13% year-over-year to 1589200.0; the TTM figure through Mar 2026 stood at 6457918.0 (up 3.7% YoY), while the FY2025 annual figure was 6053575.0, up 22.6% from the prior year.
- Cash from Operations came in at 1589200.0 for Q1 2026 at Bluejay Diagnostics, down from 1454870.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 1125066.0 in Q3 2023 to a low of 2944243.0 in Q4 2022.
- A 5-year average of 1854062.35 and a median of 1659062.0 in 2022 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations tumbled 403.8% in 2022 and surged 48.48% in 2025, its largest moves.
- Bluejay Diagnostics' Cash from Operations stood at 2944243.0 in 2022, then climbed by 5.66% to 2777477.0 in 2023, then soared by 47.75% to 1451345.0 in 2024, then fell by 0.24% to 1454870.0 in 2025, then retreated by 9.23% to 1589200.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 1589200.0, 1454870.0, and 1359793.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.74 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 220.10 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 525.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 335.40 Mn |
| 10 | Bluejay Diagnostics | 572,394.44 | -3.11 Mn | - | -1.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.59 Mn |
| Mar 31, 2026 | -1.59 Mn |
| Dec 31, 2025 | -1.45 Mn |
| Dec 31, 2025 | -1.45 Mn |
| Sep 30, 2025 | -1.36 Mn |
| Sep 30, 2025 | -1.36 Mn |
| Jun 30, 2025 | -2.05 Mn |
| Jun 30, 2025 | -2.05 Mn |
| Mar 31, 2025 | -1.18 Mn |
| Mar 31, 2025 | -1.18 Mn |
| Dec 31, 2024 | -1.45 Mn |
| Dec 31, 2024 | -1.45 Mn |
| Sep 30, 2024 | -2.15 Mn |
| Sep 30, 2024 | -2.15 Mn |
| Jun 30, 2024 | -1.91 Mn |
| Jun 30, 2024 | -1.91 Mn |
| Mar 31, 2024 | -2.30 Mn |
| Mar 31, 2024 | -2.30 Mn |
| Dec 31, 2023 | -2.78 Mn |
| Dec 31, 2023 | -2.78 Mn |
| Sep 30, 2023 | -1.13 Mn |
| Sep 30, 2023 | -1.13 Mn |
| Jun 30, 2023 | -1.48 Mn |
| Jun 30, 2023 | -1.48 Mn |
| Mar 31, 2023 | -2.93 Mn |
| Mar 31, 2023 | -2.93 Mn |
| Dec 31, 2022 | -2.94 Mn |
| Dec 31, 2022 | -2.94 Mn |
| Sep 30, 2022 | -1.26 Mn |
| Sep 30, 2022 | -1.26 Mn |
| Jun 30, 2022 | -1.66 Mn |
| Jun 30, 2022 | -1.66 Mn |
| Mar 31, 2022 | -1.88 Mn |
| Mar 31, 2022 | -1.88 Mn |
| Dec 31, 2021 | -2.52 Mn |
| Dec 31, 2021 | -2.52 Mn |
| Sep 30, 2021 | -1.11 Mn |
| Sep 30, 2021 | -1.11 Mn |
| Jun 30, 2021 | -356,181.00 |
| Jun 30, 2021 | -356,181.00 |
| Mar 31, 2021 | -372,620.00 |
| Mar 31, 2021 | -372,620.00 |
| Dec 31, 2020 | -154,856.00 |
| Dec 31, 2020 | -154,856.00 |